[
    "```\n[\n  {\n    \"question\": \"What is the next logical resistance level for Nifty?\",\n    \"answer\": \"The next logical resistance level for Nifty is 18887, which is the all-time high and the 50 percent Fibonacci extension level of the swing from June 2022 to March 2023.\",\n    \"context\": \"The only logical resistance which is expected in the Nifty from here on is the alltime high placed at 18887 which also happens to be the 50 percent Fibonacci extension level of the entire swing seen from June 2022 bottom to December 2022 top and from December 2022 top to March 2023 bottom.\"\n  },\n  {\n    \"question\": \"What is the next Fibonacci extension level for Nifty above 18887?\",\n    \"answer\": \"The next Fibonacci extension level for Nifty above 18887 is 19372, which is the 61.8 percent Fibonacci extension level.\",\n    \"context\": \"Above 18887 the next resistance comes in at 61.8 percent Fibonacci extension placed at 19372 in Nifty.\"\n  },\n  {\n    \"question\": \"What is the current short-term support level for Nifty?\",\n    \"answer\": \"The current short-term support level for Nifty is 18450, which is the previous swing high on the short-term chart.\",\n    \"context\": \"Shortterm support for the Nifty has shifted up to 18450 which happens to be the previous swing high on the shortterm chart.\"\n  },\n  {\n    \"question\": \"What is the far support level for Nifty?\",\n    \"answer\": \"The far support level for Nifty is in the range of 18200-18250.\",\n    \"context\": \"Far support is placed in the range of 1820018250.\"\n  },\n  {\n    \"question\": \"What is the percentage of stocks above their 200 DMA?\",\n    \"answer\": \"The percentage of stocks above their 200 DMA is 62%.\",\n    \"context\": \"Breadth of the market is going very strong as a percentage of stocks above their respective 200 DMA have reached at 62.\"\n  },\n  {\n    \"question\": \"What is the recommended stop-loss level for short-term traders in Nifty?\",\n    \"answer\": \"The recommended stop-loss level for short-term traders in Nifty is 18450.\",\n    \"context\": \"Short term traders are advised to hold longs with a stoploss of 18450.\"\n  },\n  {\n    \"question\": \"What is the expected target price for Equitas Small Finance Bank?\",\n    \"answer\": \"The expected target price for Equitas Small Finance Bank is Rs 96, which represents a potential return of 12.4 percent.\",\n    \"context\": \"The stock price has registered new alltime high with rise in volumes. Primary trend of the stock is bullish as it has been forming higher tops and higher bottoms on the weekly charts.The stock is placed above all important moving average indicating bullish trend on all time frames. Indicators and oscillators like MACD (moving average convergence divergence) and RSI (relative strength index) have turned bullish on its weekly charts. NBFC and Banking sector have been outperforming for last two months.\"\n  },\n  {\n    \"question\": \"What is the recommended stop-loss level for positional traders in Nifty?\",\n    \"answer\": \"The recommended stop-loss level for positional traders in Nifty is 18200.\",\n    \"context\": \"Positional traders should keep 18200 stoploss in Nifty.\"\n  }\n]\n```\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"What is the short-term resistance level for the Nifty based on derivatives data?\",\n        \"answer\": \"The significant Call writing happening at the 18500 strike price in the weekly expiry suggests that 18500 could act as a resistance level for the Nifty in the short term.\",\n        \"context\": \"From the derivatives perspective, there has been a significant Call writing happening at 18500 strike price in the weekly expiry which could offer a resistance in the Nifty for the short term.\"\n    },\n    {\n        \"question\": \"What technical indicator suggests a potential bullish trend reversal for Mastek?\",\n        \"answer\": \"Mastek's stock price broke out from consolidation with a significant jump in volumes on the week ended April 21, 2023, and resumed its uptrend after a correction from the recent swing high on May 2, 2022, indicating a potential bullish trend reversal.\",\n        \"context\": \"On the week ended April 21, 2023, the stock price broke out from consolidation with significant jump in volumes. On May 2, 2022, the stock resumed its uptrend after running correction from the recent swing high.\"\n    },\n    {\n        \"question\": \"What is the rationale behind the buy call for CCL Products?\",\n        \"answer\": \"The buy call for CCL Products is based on its bullish primary trend, support from its 50-day EMA, breakout from a symmetrical triangle on the daily chart with a new all-time high, price rise accompanied by a jump in volumes, and bullish indicators and oscillators on daily and weekly charts.\",\n        \"context\": \"Primary trend of the stock has been bullish as it has been forming higher tops and higher bottoms on weekly charts. Stock price has been finding support on its 50day EMA.The stock has broken out from symmetrical triangle on the daily chart and registered new all time high. Price rise is accompanied by jump in volumes. Indicators and oscillators have turned bullish on daily and weekly charts.\"\n    },\n    {\n        \"question\": \"What recent price action suggests a positive outlook for Apollo Hospitals Enterprises?\",\n        \"answer\": \"Apollo Hospitals Enterprises has experienced a rising stock price for the last three weeks with rising volumes and a breakout from a downward-sloping trend line on the weekly charts, indicating a positive outlook.\",\n        \"context\": \"Stock price has been rising for last three weeks with rising volumes. Stock price has broken out from downward sloping trend line on the weekly charts.\"\n    },\n    {\n        \"question\": \"What is the current trend of the Nifty based on its moving average support?\",\n        \"answer\": \"The Nifty is currently in an uptrend as it has not breached its nearest moving average support of the five-day EMA (exponential moving average) placed at 18310.\",\n        \"context\": \"The Nifty is in continuation of an uptrend as it has not even breached its nearest moving average support of fiveday EMA (exponential moving average) placed at 18310.\"\n    },\n    {\n        \"question\": \"What does the India VIX indicate about the current market volatility?\",\n        \"answer\": \"The India VIX remaining near historically lower bands indicates lower volatility and stable prices for Nifty50 stocks.\",\n        \"context\": \"India VIX continued to remain near the historically lower band which indicates lower volatility and stable prices for the Nifty50 stocks.\"\n    },\n    {\n        \"question\": \"How has the Nifty Smallcap index performed in recent weeks?\",\n        \"answer\": \"The Nifty Smallcap index has been rising for the last seven consecutive weeks and has rallied more than 14 percent during this period.\",\n        \"context\": \"The Nifty Smallcap index has been rising for the last seven consecutive weeks and has registered a rally of more than 14 percent in this period.\"\n    },\n    {\n        \"question\": \"What is the overall market sentiment based on the Nifty's recent performance and technical indicators?\",\n        \"answer\": \"The overall market sentiment appears to be bullish, given the Nifty's recent uptrend, support from its moving averages, and the historically low India VIX.\",\n        \"context\": \"Considering the evidences discussed above we believe that Nifty should be held long with trailing stoploss of 18200. On the upside 18500 is strong resistance for Nifty sustaining above which rally could extend towards all time high of 18887.\"\n    }\n]\n```\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"What is the outlook for the Nifty50 according to Sameet Chavan of Angel One, and what levels should traders watch?\",\n        \"answer\": \"Sameet Chavan believes the Nifty50 is in a bullish uptrend and expects it to reach the 18200-18500 range soon. He advises traders to buy on dips, with immediate supports at 17900-17700 and a critical support level at 17500.\",\n        \"context\": \"The benchmark Nifty50 reclaimed the 18000 mark for the first time since December 2022, showing a strong bullish sentiment. Technical indicators, including a long bullish candlestick pattern and positive momentum, support this outlook. Sameet Chavan, Head Research - Technical and Derivatives at Angel One, highlights the significance of the Nifty50 holding above its 200-day moving average (SMA) around 17600-17550, now acting as crucial support.  He anticipates the index to target the 18200-18500 cluster shortly. Considering this positive momentum, Chavan advises traders to capitalize on potential dips by adding bullish positions. \"\n    },\n    {\n        \"question\": \"What recent market activity suggests a potential bullish trend for Chennai Petroleum Corporation (CPCL) according to Kotak Securities?\",\n        \"answer\": \"Kotak Securities points to CPCL's recent price jump to Rs 318 with significant volume, reminiscent of June 2022 when the stock reached Rs 418. This, along with a rounding bottom pattern formation, suggests a potential upward movement for CPCL.\",\n        \"context\": \"Chennai Petroleum Corporation (CPCL) is showing signs of a potential bullish trend.  The stock demonstrated a significant price increase to Rs 318, accompanied by substantial trading volume.  This price action mirrors a similar move witnessed in June 2022, where the stock eventually climbed to Rs 418. Further strengthening this bullish outlook, CPCL is forming a rounding bottom pattern. This technical formation indicates a period of bullish consolidation and suggests a potential for the stock to appreciate towards Rs 370 or even Rs 400 in the medium term. \"\n    },\n    {\n        \"question\": \"What technical analysis does HDFC Securities provide to support a 'Buy' recommendation for La Opala RG?\",\n        \"answer\": \"HDFC Securities recommends buying La Opala RG as it has broken out of a downward sloping trendline with high volume, indicating a potential uptrend. The RSI and MFI are above 60, signaling strength, and the DI and ADX further support the bullish momentum.\",\n        \"context\": \"HDFC Securities suggests a 'Buy' recommendation for La Opala RG based on strong technical indicators. The stock recently broke out of a downward sloping trendline, which connected the highs of December 9, 2022, and April 11, 2023. This breakout was accompanied by a significant surge in trading volume, indicating strong positive momentum. Furthermore, both the Relative Strength Index (RSI) and Money Flow Index (MFI) are positioned above 60, reflecting underlying strength in the stock's upward movement.  Additional technical indicators like the positive Directional Indicator (+DI) surpassing the negative Directional Indicator (-DI) and the Average Directional Index (ADX) residing above 25, further confirm this bullish momentum.\"\n    },\n    {\n        \"question\": \"Why does Bonanza Portfolio recommend buying Hindustan Petroleum Corporation (HPCL), and what is the target price?\",\n        \"answer\": \"Bonanza Portfolio suggests buying HPCL with a target price of Rs 274. They base this on the stock forming an inverted head and shoulders pattern and a bullish engulfing candlestick pattern, indicating potential bullish momentum.\",\n        \"context\": \"Bonanza Portfolio has identified several technical indicators supporting a 'Buy' recommendation for Hindustan Petroleum Corporation (HPCL). The stock has been consolidating above its high-volume zone, forming an Inverted Head and Shoulders pattern, which is typically a bullish signal. This pattern suggests a potential reversal of the previous downtrend and the beginning of an uptrend. Further strengthening this bullish outlook is the formation of a Bullish Engulfing candlestick pattern on the weekly chart. This pattern, characterized by a large bullish candle engulfing the previous bearish candle, also indicates a potential shift in sentiment towards buying. These observations, coupled with the price action relative to the Bollinger Bands and the positive crossover in the Stochastic RSI indicator, lead Bonanza Portfolio to believe that HPCL could reach Rs 274. \"\n    },\n    {\n        \"question\": \"According to 5paisa.com, what technical factors suggest a\"\n    }\n]\n",
    "[\n  {\n    \"question\": \"What caused the market to rebound after a rout in the previous week?\",\n    \"answer\": \"The market rebounded after a rout in the previous week due to a smart rally of 1.5 percent on Friday.\",\n    \"context\": \"After a rout in the previous week the market rebounded with more than half a percent gains for week ended March 3 driven by Friday s smart rally of 1.5 percent.\"\n  },\n  {\n    \"question\": \"What is the significance of the bullish candlestick pattern formed by the Nifty50?\",\n    \"answer\": \"The bullish candlestick pattern formed by the Nifty50 indicates support-based buying at lower levels and signals chances of upside bounce for the market.\",\n    \"context\": \"The Nifty50 has formed a decent bullish candlestick pattern with long lower shadow on the weekly scale indicating supportbased buying at lower levels.\"\n  },\n  {\n    \"question\": \"What are the expected resistance and support levels for the Nifty50 in the coming sessions?\",\n    \"answer\": \"The expected resistance levels for the Nifty50 in the coming sessions are 17700-17800, while the support levels are 17400-17255.\",\n    \"context\": \"In the coming sessions 1770017800 levels (5 and 21 EMA  exponential moving average on weekly scale) are expected to be next resistance area for the index and if the said levels get passed then psychological 18000 mark which coincides with 20day SMA (simple moving average) is likely to be crucial hurdle with the support at 1740017255 area experts said.\"\n  },\n  {\n    \"question\": \"What is the immediate support zone for the Nifty50?\",\n    \"answer\": \"The immediate support zone for the Nifty50 is 17500.\",\n    \"context\": \"17500 is now likely to be seen as the immediate support zone while the sacrosanct support lies around the 1735017400 zone coinciding with the 200 SMA.\"\n  },\n  {\n    \"question\": \"What is the bearish gap that is expected to act as a hurdle for Nifty?\",\n    \"answer\": \"The bearish gap of 17770-17800 is expected to act as a hurdle for Nifty in the coming period.\",\n    \"context\": \"On the flip side the bearish gap of 1777017800 is expected to act as the sturdy hurdle for Nifty in a comparable period  Sameet Chavan Chief AnalystTechnical and Derivatives at Angel One said.\"\n  },\n  {\n    \"question\": \"What is the recommendation of Sameet Chavan for traders in the near period?\",\n    \"answer\": \"Sameet Chavan recommends traders to utilize dips to add long positions in the Nifty index and keep a close tab on the midcap space for trading opportunities.\",\n    \"context\": \"Going forward he advised the traders to utilize the dips to add long position in the index.Simultaneously one should also keep a close tab on the midcap space which is expected to provide immense trading opportunities in the near period he said.\"\n  },\n  {\n    \"question\": \"What is the target price set by Shrikant Chouhan for Apollo Hospitals?\",\n    \"answer\": \"Rs 4550\",\n    \"context\": \"Apollo Hospitals  Buy   LTP  Rs 4408   StopLoss  Rs 4300   Target  Rs 4550   Return  3 percent\"\n  },\n  {\n    \"question\": \"What is the technical reason for buying Mukand according to the expert?\",\n    \"answer\": \"Mukand has been forming a Double Bottom and has validated the formation by crossing Rs 136 level.\",\n    \"context\": \"It has been forming a Double Bottom for the past few days. However on last Friday it validated a formation by crossing Rs 136 level.\"\n  }\n]",
    "```python\n[\n    {\n        \"question\": \"What were Apollo Hospital's net sales in December 2022, and how did this figure compare to the previous year?\",\n        \"answer\": \"Apollo Hospital recorded net sales of Rs 4263.58 crore in December 2022. This represents a 17.17% increase compared to Rs. 3638.93 crore in December 2021.\",\n        \"context\": \"The provided financial data highlights Apollo Hospital's performance in December 2022 against its performance in the same period the previous year.  Net sales are a key indicator of a company's top-line growth, and a year-over-year increase suggests positive momentum in revenue generation.\"\n    },\n    {\n        \"question\": \"How did Apollo Hospital's quarterly net profit in December 2022 compare to December 2021?\",\n        \"answer\": \"Apollo Hospital's quarterly net profit in December 2022 was Rs. 153.46 crore. This signifies a decrease of 32.8% from the Rs. 228.37 crore profit reported in December 2021.\",\n        \"context\": \"While Apollo Hospital experienced net sales growth, its profitability declined in December 2022 compared to the previous year.  A decrease in net profit could be attributed to various factors, including increased expenses, higher taxes, or a change in the company's cost structure.\"\n    },\n    {\n        \"question\": \"What was the EBITDA for Apollo Hospital in December 2022, and what was the year-over-year change?\",\n        \"answer\": \"In December 2022, Apollo Hospital reported EBITDA of Rs. 540.71 crore. This represents a 10.5% decrease compared to the Rs. 604.17 crore EBITDA reported in December 2021.\",\n        \"context\": \"EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is a measure of a company's operating profitability.  Apollo Hospital experienced a decline in EBITDA in December 2022 compared to the previous year. This suggests potential pressure on the company's core operating performance.\"\n    },\n    {\n        \"question\": \"What was the change in Apollo Hospital's EPS from December 2021 to December 2022?\",\n        \"answer\": \"Apollo Hospital's EPS decreased to Rs. 10.67 in December 2022, down from Rs. 15.88 in December 2021.\",\n        \"context\": \"Earnings per share (EPS) is a crucial metric for evaluating a company's profitability on a per-share basis. The decrease in Apollo Hospital's EPS suggests a decline in the company's profitability relative to its outstanding shares.\"\n    },\n    {\n        \"question\": \"What was the closing price of Apollo Hospital shares on February 16, 2023, on the NSE?\",\n        \"answer\": \"Apollo Hospital shares closed at Rs. 4643.15 on the National Stock Exchange (NSE) on February 16, 2023.\",\n        \"context\": \"The provided text includes Apollo Hospital's closing stock price on a specific date, indicating its market valuation on that day. This information is essential for investors tracking the company's stock performance.\"\n    },\n    {\n        \"question\": \"What was the 6-month return on Apollo Hospital shares as of February 16, 2023?\",\n        \"answer\": \"As of February 16, 2023, Apollo Hospital shares had generated a return of 6.75% over the preceding six months.\",\n        \"context\": \"This data point reveals the performance of Apollo Hospital shares over a recent six-month period, offering insight into the investment returns for shareholders who held the stock during that timeframe.\"\n    },\n    {\n        \"question\": \"What was the 12-month return on Apollo Hospital shares as of February 16, 2023?\",\n        \"answer\": \"Apollo Hospital shares yielded a 1.27% return over the 12 months leading up to February 16, 2023.\",\n        \"context\": \"This information presents the performance of Apollo Hospital shares over the past year, indicating the return on investment for investors who held the stock during that period. A 1.27% return suggests a relatively stable performance with modest growth.\"\n    },\n    {\n        \"question\": \"Considering the financial performance of Apollo Hospital, what might\"\n    }\n]\n",
    "```\n[ \n         {  \"question\": \"What is the revenue growth rate of CrowdStrike? \",\n             \"answer\": \"CrowdStrike's revenue growth rate was 63% in fiscal 2022. \", \n             \"context\": \"CrowdStrike, a cloud-based cybersecurity company, has consistently delivered impressive financial performance. In fiscal 2022, the company reported revenue growth of 63%, driven by strong demand for its cloud-native cybersecurity solutions. \"\n         },\n\n         {  \"question\": \"What is the profit margin of Snowflake?\", \n            \"answer\": \"Snowflake's profit margin was 14% in fiscal 2022. \", \n            \"context\": \"Snowflake, a cloud-based data warehousing company, has achieved strong profitability in recent years. In fiscal 2022, the company reported a profit margin of 14%, reflecting its efficient business model and operating leverage. \"\n         },\n\n         {  \"question\": \"What is the customer retention rate of Salesforce? \", \n            \"answer\": \"Salesforce's customer retention rate is approximately 90%. \", \n            \"context\": \"Salesforce, a leading provider of customer relationship management (CRM) software, has built a loyal customer base. The company's customer retention rate is approximately 90%, indicating its ability to retain and grow its customer relationships over time. \"\n         },\n\n         {  \"question\": \"What is the debt-to-equity ratio of Adobe? \", \n            \"answer\": \"Adobe's debt-to-equity ratio is 0.21 as of 2022. \", \n            \"context\": \"Adobe, a creative software company, maintains a solid financial position. The company's debt-to-equity ratio is 0.21 as of 2022, indicating a conservative approach to debt financing. \"\n         },\n\n         {  \"question\": \"What is the free cash flow yield of Microsoft? \",\n            \"answer\": \"Microsoft's free cash flow yield is approximately 5.5% as of 2022. \", \n            \"context\": \"Microsoft, a technology giant, generates substantial free cash flow. The company's free cash flow yield, which is the ratio of free cash flow to market capitalization, is approximately 5.5% as of 2022, providing investors with a compelling return on their investment. \"\n         },\n\n         {  \"question\": \"What is the dividend payout ratio of Walmart? \",\n            \"answer\": \"Walmart's dividend payout ratio is approximately 50% as of 2022. \", \n            \"context\": \"Walmart, a retail giant, has a history of paying dividends to its shareholders. The company's dividend payout ratio, which is the percentage of earnings paid out as dividends, is approximately 50% as of 2022, indicating a commitment to returning cash to shareholders. \"\n         },\n\n         {  \"question\": \"What is the price-to-earnings ratio of Amazon? \",\n            \"answer\": \"Amazon's price-to-earnings ratio is approximately 55 as of 2022. \", \n            \"context\": \"Amazon, an e-commerce and cloud computing leader, trades at a premium valuation. The company's price-to-earnings ratio, which is the ratio of its stock price to its annual earnings per share, is approximately 55 as of 2022, reflecting investors' expectations for continued growth and profitability. \"\n         },\n\n         {  \"question\": \"What is the market capitalization of Apple? \",\n            \"answer\": \"Apple's market capitalization is over $2 trillion as of 2022. \", \n            \"context\": \"Apple, the iconic technology company, is among the largest companies in the world. The company's market capitalization, which is the total value of its outstanding shares, is over $2 trillion as of 2022, demonstrating its dominance in the tech industry. \"\n         }\n    ]\n```\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"How did Apollo Hospitals Enterprise's stock perform on February 14th, and what was the reason?\",\n        \"answer\": \"Apollo Hospitals Enterprise's shares declined in early trading on February 14th as investors became cautious prior to the company's scheduled Q3 earnings release later that day.\",\n        \"context\": \"The provided text details the stock performance and anticipated financial results of Apollo Hospitals Enterprise leading up to their Q3 earnings announcement.  Investors reacted with caution, causing an early dip in share prices, likely driven by uncertainty surrounding the upcoming results.\"\n    },\n    {\n        \"question\": \"What revenue growth is projected for Apollo Hospitals Enterprise in the third quarter, and what are the contributing factors?\",\n        \"answer\": \"Apollo Hospitals Enterprise is expected to achieve revenue growth in the mid-teens year-on-year, reaching Rs 4177.50 crore, driven by factors such as an improved revenue mix, the normalization of medical tourism, and increased pharmacy sales.\",\n        \"context\": \"The text highlights positive expectations for Apollo Hospitals Enterprise's revenue, predicting mid-teen growth.  This anticipated success is linked to multiple factors, including a favorable shift in revenue sources, a resurgence in medical tourism, and strong performance in pharmacy sales.\"\n    },\n    {\n        \"question\": \"How does Apollo Hospitals Enterprise's Q3 2023 revenue compare to its revenue in the same period last year?\",\n        \"answer\": \"In Q3 of the previous year, Apollo Hospitals Enterprise recorded a net profit of Rs 228.4 crore on revenue of Rs 3638.9 crore, indicating a substantial year-on-year increase in revenue.\",\n        \"context\": \"The provided data allows for a direct comparison of Apollo Hospitals Enterprise's Q3 revenue year-on-year.  The projected revenue for the current year demonstrates significant growth compared to the Rs 3638.9 crore generated in the same quarter of the previous year.\"\n    },\n    {\n        \"question\": \"What factors are anticipated to negatively impact Apollo Hospitals Enterprise's Q3 profitability?\",\n        \"answer\": \"Despite the positive revenue outlook, Apollo Hospitals Enterprise's profitability in Q3 is likely to be hampered by elevated operational expenses and compressed margins.\",\n        \"context\": \"The passage reveals a nuanced view of Apollo Hospitals Enterprise's financial picture.  While revenue is projected to grow, concerns are raised regarding increasing operating costs and subsequent pressure on profit margins.\"\n    },\n    {\n        \"question\": \"What is the projected net profit for Apollo Hospitals Enterprise in Q3, and how does it compare to the previous year?\",\n        \"answer\": \"Brokerage forecasts predict Apollo Hospitals Enterprise's net profit for the quarter to reach Rs 229.7 crore, reflecting a marginal 1% year-on-year increase.\",\n        \"context\": \"Despite projecting a significant revenue increase, projections anticipate only a slight rise in Apollo Hospitals Enterprise's net profit.  This suggests that while the company is set to generate more revenue, increased expenses are expected to offset much of the profit potential.\"\n    },\n    {\n        \"question\": \"How is Apollo Hospitals Enterprise's investment in Apollo 24x7 expected to affect its EBIDTA margin?\",\n        \"answer\": \"Despite the anticipated rise in revenue, Apollo Hospitals Enterprise's EBIDTA margin is expected to shrink year-on-year due to increased spending on Apollo 24x7.\",\n        \"context\": \"The text reveals a strategic decision by Apollo Hospitals Enterprise to invest in its Apollo 24x7 platform.  While this investment is anticipated to contribute to revenue growth, it also brings increased expenses, which are projected to impact the company's EBIDTA margin negatively.\"\n    },\n    {\n        \"question\": \"What EBIDTA margin does ICICI Securities project for Apollo Hospitals Enterprise in Q3?\",\n        \"answer\": \"ICICI Securities estimates Apollo Hospitals Enterprise's EBIDTA margin to contract by 300 basis points year-on-year, reaching 13.1% for the quarter.\",\n        \"context\": \"ICICI Securities provides a specific projection for Apollo Hospitals Enterprise's EBIDTA margin, forecasting a significant contraction compared to the previous year.  This prediction further reinforces the anticipated impact of increased expenses, potentially linked to investments like Apollo 24x7, on the company's profitability.\"\n    },\n    {\n        \"question\": \"What was Apollo Hospitals Enterprise's EBIDTA margin in the corresponding quarter of the previous year?\",\n        \"answer\": \"Apollo Hospitals Enterprise achieved an EBIDTA margin of 16.1% in the same quarter of the previous year, highlighting a substantial decline anticipated in the current year.\",\"\n    }\n]\n",
    "```python\n[\n    {  \"question\": \"What is the resistance zone for LKP Securities' Nifty50 index analysis?\",\n        \"answer\": \"The resistance zone for LKP Securities' Nifty50 index analysis is around 18300-18350.\", \n        \"context\": \"According to Kunal Shah, Senior Technical Derivative Analyst at LKP Securities, the Nifty50 index is facing selling pressure around the resistance zone of 18300-18350. The options data also indicates a significant hurdle at 18300, where the highest open interest was built up. This suggests that a strong resistance level exists at this point, making it difficult for the index to break through easily.\"\n    },\n    {  \"question\": \"What does LKP Securities' options data indicate about the Nifty50 index at 18300?\",\n        \"answer\": \"LKP Securities' options data shows the highest open interest buildup at the 18300 level for the Nifty50 index, suggesting it's a significant hurdle.\", \n        \"context\": \"Kunal Shah, Senior Technical Derivative Analyst at LKP Securities, points out that the options data reveals the highest open interest buildup for the Nifty50 index occurred at the 18300 level.  This high open interest signals a substantial resistance point at 18300, making it a critical level to watch for traders. A breakout above this level could trigger further upward movement, while a failure to break through could lead to a pullback.\"\n    },\n    {  \"question\": \"What is the support zone for LKP Securities' Bank Nifty index analysis?\",\n        \"answer\": \"The support zone for LKP Securities' Bank Nifty index analysis is 42500-42400.\", \n        \"context\": \"LKP Securities identifies a critical support zone for the Bank Nifty index between 42500 and 42400. This zone is considered significant as the index has managed to hold above these levels. As long as the Bank Nifty trades above this support zone, a buy-on-dip approach is recommended. A break below this support could signal a shift in momentum and potentially lead to further downside.\"\n    },\n    {  \"question\": \"Where does LKP Securities see the next resistance level for the Bank Nifty index?\",\n        \"answer\": \"LKP Securities identifies the next resistance level for the Bank Nifty index at 43000, where the highest open interest was built up on the Call side.\", \n        \"context\": \"LKP Securities highlights that the Bank Nifty index faces an obstacle at the 43000 level. This level holds significance due to the considerable open interest buildup on the Call side, indicating potential selling pressure.  Traders will closely observe if the index can overcome this resistance. A successful break above 43000 might attract further buying and propel the index higher.\"\n    },\n    {  \"question\": \"Why does LKP Securities recommend buying Fertilisers and Chemicals Travancore stock?\",\n        \"answer\": \"LKP Securities recommends buying Fertilisers and Chemicals Travancore due to the stock's strong breakout from a large consolidation range with good volume, confirmed by bullish momentum oscillators.\", \n        \"context\": \"LKP Securities is bullish on Fertilisers and Chemicals Travancore as the stock showcases a powerful breakout from a prolonged consolidation phase, accompanied by significant trading volume. This breakout, supported by strong buying pressure, is further validated by positive momentum oscillators, indicating growing bullish momentum.\"\n    },\n    {  \"question\": \"What technical analysis indicators support LKP Securities' buy call for Apollo Hospitals Enterprises?\",\n        \"answer\": \"LKP Securities' buy call for Apollo Hospitals Enterprises is supported by a breakout from a sideways trend with rising volumes, fresh long buildups in F&O data, and a positive crossover in the RSI momentum indicator.\", \n        \"context\": \"LKP Securities justifies its buy recommendation for Apollo Hospitals Enterprises based on several technical factors. The stock has broken out of a sideways trading pattern with increasing volume, signaling rising buying interest. Additionally,  fresh long positions are being built in the F&O market, reflecting positive sentiment. Furthermore, the RSI momentum indicator confirms this bullish outlook with a positive crossover, suggesting potential for further upside.\"\n    },\n    {  \"question\": \"How does LKP Securities interpret the recent price action in Aditya Birla Capital stock?\",\n        \"answer\": \"LKP Securities observes that Aditya Birla Capital stock, after a recent breakout, has retested its support zone and resumed an upward movement with increased volume, indicating a bullish trend.\", \n        \"context\": \"LKP Securities is encouraged by the price action in Aditya Birla Capital stock.  Following\"\n    }\n]\n",
    "```\n[\n  {\n    \"question\": \"What was the net sales of Apollo Hospital in September 2022?\",\n    \"answer\": \"Rs. 1715.58 crore\",\n    \"context\": \"The net sales at Apollo Hospital was Rs 1715.58 crore in September 2022 down 39.23  from Rs. 2823.20 crore in September 2021.\"\n  },\n  {\n    \"question\": \"How much has the Quarterly Net Profit increased in September 2022 compared to September 2021 at Apollo Hospital?\",\n    \"answer\": \"50.19%\",\n    \"context\": \"The quarterly net profit at Apollo Hospital was Rs. 279.19 crore in September 2022 up 50.19  from Rs. 185.89 crore in September 2021.\"\n  },\n  {\n    \"question\": \"What was the EBITDA of Apollo Hospital in September 2022?\",\n    \"answer\": \"Rs. 495.98 crore\",\n    \"context\": \"The EBITDA stands at Rs. 495.98 crore in September 2022 up 10.92  from Rs. 447.15 crore in September 2021.\"\n  },\n  {\n    \"question\": \"Has the EPS of Apollo Hospital increased or decreased in September 2022 compared to September 2021?\",\n    \"answer\": \"Increased\",\n    \"context\": \"The Apollo Hospital EPS has increased to Rs. 19.42 in September 2022 from Rs. 12.93 in September 2021.\"\n  },\n  {\n    \"question\": \"What was the closing price of Apollo Hospital shares on November 10, 2022?\",\n    \"answer\": \"4285.45\",\n    \"context\": \"The Apollo Hospital shares closed at 4285.45 on November 10 2022 (NSE).\"\n  },\n  {\n    \"question\": \"What is the return on Apollo Hospital shares over the last 6 months?\",\n    \"answer\": \"16.23%\",\n    \"context\": \"The Apollo Hospital shares have given 16.23  returns over the last 6 months and 5.87  over the last 12 months.\"\n  },\n  {\n    \"question\": \"What is the return on Apollo Hospital shares over the last 12 months?\",\n    \"answer\": \"5.87%\",\n    \"context\": \"The Apollo Hospital shares have given 16.23  returns over the last 6 months and 5.87  over the last 12 months.\"\n  },\n  {\n    \"question\": \"In which month and year did Apollo Hospital have the highest quarterly net profit?\",\n    \"answer\": \"September 2022\",\n    \"context\": \"The quarterly net profit at Apollo Hospital was Rs. 279.19 crore in September 2022 up 50.19  from Rs. 185.89 crore in September 2021.\"\n  }\n]\n```\"\n    }\n]\n",
    "[{'question': 'What was the percentage change in Apollo Hospital\\'s Net Sales between September 2021 and September 2022?', 'answer': 'Apollo Hospital\\'s Net Sales increased by 14.37%, rising from Rs. 3717.07 crore in September 2021 to Rs. 4251.07 crore in September 2022.', 'context': 'The provided data highlights key financial figures for Apollo Hospital, comparing its performance between September 2021 and September 2022. Notably, Net Sales demonstrated positive growth, increasing by 14.37% to reach Rs. 4251.07 crore in September 2022 from Rs. 3717.07 crore in the same month of the previous year.'}, {'question': 'How did Apollo Hospital\\'s Quarterly Net Profit fare in September 2022 compared to September 2021?', 'answer': 'Apollo Hospital witnessed a decrease in Quarterly Net Profit, dropping by 17.69% to Rs. 203.99 crore in September 2022 from Rs. 247.82 crore in September 2021.', 'context': 'While Apollo Hospital recorded an increase in Net Sales, its Quarterly Net Profit experienced a decline. In September 2022, the Quarterly Net Profit stood at Rs. 203.99 crore, reflecting a decrease of 17.69% compared to Rs. 247.82 crore in September 2021.'}, {'question': 'What was the EBITDA of Apollo Hospital in September 2022, and how did it compare to the same period in 2021?', 'answer': 'Apollo Hospital\\'s EBITDA in September 2022 was Rs. 587.94 crore, indicating a 5.27% decrease from Rs. 620.62 crore in September 2021.', 'context': 'The provided financial data indicates that Apollo Hospital\\'s EBITDA also experienced a decline. In September 2022, the EBITDA reached Rs. 587.94 crore, representing a 5.27% decrease from Rs. 620.62 crore in September 2021.'}, {'question': 'Did Apollo Hospital\\'s EPS increase or decrease between September 2021 and September 2022?', 'answer': 'Apollo Hospital\\'s EPS decreased from Rs. 17.24 in September 2021 to Rs. 14.19 in September 2022.', 'context': 'The financial data for Apollo Hospital shows a decrease in its EPS. In September 2022, the EPS was recorded at Rs. 14.19, down from Rs. 17.24 in September 2021.'}, {'question': 'What was the closing price of Apollo Hospital\\'s shares on November 10, 2022, on the NSE?', 'answer': 'Apollo Hospital\\'s shares closed at Rs. 4285.45 on the NSE on November 10, 2022.', 'context': 'As of November 10, 2022, Apollo Hospital\\'s shares on the NSE closed at Rs. 4285.45. This information provides a snapshot of the company\\'s stock performance on that particular date.'}, {'question': 'What was the percentage return of Apollo Hospital\\'s shares over the past six months as of November 10, 2022?', 'answer': 'Apollo Hospital\\'s shares generated a return of 16.23% over the six months leading up to November 10, 2022.', 'context': 'Over the six-month period preceding November 10, 2022, Apollo Hospital\\'s shares demonstrated a positive return of 16.23%. This figure indicates the percentage gain an investor would have experienced by holding the company\\'s shares during that time frame.'}, {'question': 'What was the percentage return of Apollo Hospital\\'s shares over the past twelve months as of November 10, 2022?', 'answer': 'Apollo Hospital\\'s shares yielded a return of 5.87% over the twelve months leading up to November 10, 2022.', 'context': 'Looking at a longer timeframe, Apollo Hospital\\'s shares provided a return of 5.87% over the twelve months leading up to November 10, 2022. This metric offers insights into the company\\'s stock performance\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"What is the short-term outlook for the Nifty according to the analysis?\",\n        \"answer\": \"The Nifty is expected to remain sideways in the short term until it breaks out of the 17500-17800 range with confirmation.\",\n        \"context\": \"On the daily chart the Nifty has formed a Doji after taking resistance from the 17800 levels. On the hourly timeframe the Nifty was seen to be trading in a range of 17500 and 17800 and till it breaks the range on either side with confirmation it is expected to remain sideways and it would be interesting to see how it performs.\"\n    },\n    {\n        \"question\": \"What technical indicators suggest a bearish outlook for Amara Raja Batteries?\",\n        \"answer\": \"Amara Raja Batteries stock has been falling continuously in a well-channelized manner, reversing from the upper Bollinger Band with bearish engulfing candlesticks. Additionally, the RSI (14) reading is below 50, indicating a bearish setup.\",\n        \"context\": \"The price of Amara Raja Batteries has been falling continuously in a well-channelized manner from the last couple of weeks. Every time it has touched, the prices have respected the bearish channel's upper and lower bands. In addition, the price has also reversed from the upper Bollinger Band with Bearish Engulfing candlesticks which indicates a bearish setup in the counter. Moreover, a momentum indicator RSI (14) reading is below 50 levels which suggests a bearish move for the midterm.\"\n    },\n    {\n        \"question\": \"What is the target price for Apollo Hospitals Enterprises and what is the rationale behind it?\",\n        \"answer\": \"The target price for Apollo Hospitals is Rs 4850. The stock is trading in bullish territory after breaking out of a falling channel and reclaiming the upper band. It has formed a bullish engulfing candlestick pattern on a weekly scale and is trading above the 100-day exponential moving average, indicating a positive trend. The Ichimoku Cloud and RSI (14) above 60 also support the bullish outlook.\",\n        \"context\": \"On a daily chart, the stock is trading in bullish territory after the breakout of the Falling channel and again reclaiming the upper band of the pattern which indicates upward direction in the stock for the short to medium term. On the weekly scale, it has formed a Bullish Engulfing candlestick which points out a positive trend in the midterm. In addition, the price is trading above the 100 days exponential moving average which indicates a positive trend. Moreover, the technical indicator Ichimoku Cloud suggests that the price is trading above the cloud which shows a positive trend in the counter. A momentum indicator RSI (14) reading is above 60 levels which adds more strength on the upside. Hence based on the above technical structure, one can initiate a long position in stock at Rs 4604.80 or a fall in the price till Rs 4590 levels can be used as a buying opportunity for the upside target of Rs 4850.\"\n    },\n    {\n        \"question\": \"What is the significance of the Nifty's PutCall ratio (PCR) and Bank Nifty PCR?\",\n        \"answer\": \"The Nifty PCR is at 0.75 and the Bank Nifty PCR is at 0.84, which suggests a cautious sentiment among traders.\",\n        \"context\": \"Nifty PutCall ratio (PCR) is at 0.75 whereas Bank Nifty PCR is at 0.84.\"\n    },\n    {\n        \"question\": \"What levels should investors watch for a potential short position in Amara Raja Batteries?\",\n        \"answer\": \"Investors can initiate a short position in Amara Raja Batteries October futures at Rs 512.45 or on a rise up to Rs 519.50 for a downside target of Rs 494.\",\n        \"context\": \"Hence based on the above technical structure, one can initiate a short position in Amara Raja October futures at Rs 512.45 or a rise in the price till Rs 519.50 levels can be used as a selling opportunity for the downside target of Rs 494.\"\n    },\n    {\n        \"question\": \"Where does the significant support and resistance levels lie for Nifty?\",\n        \"answer\": \"For the Nifty, key support levels are at 17500, 17400, and 17350, while resistance levels are at 17650, 17750, and 18000.\",\n        \"context\": \"Important support levels\"\n    }\n]\n",
    "[{'question': 'What was the percentage change in Apollo Hospital\\'s Net Sales in June 2022 compared to June 2021?',\n  'answer': 'Apollo Hospital\\'s Net Sales in June 2022 increased by 0.94% compared to June 2021.',\n  'context': 'The passage states that Apollo Hospital recorded Net Sales of Rs 3795.60 crore in June 2022, which is a 0.94% increase from Rs. 3760.21 crore in June 2021.'},\n {'question': 'How did Apollo Hospital\\'s Quarterly Net Profit in June 2022 compare to June 2021?',\n  'answer': 'Apollo Hospital\\'s Quarterly Net Profit in June 2022 decreased by 35.19% compared to June 2021.',\n  'context': 'The provided financial information indicates that Apollo Hospital\\'s Quarterly Net Profit was Rs. 317.11 crore in June 2022, reflecting a 35.19% decrease from Rs. 489.28 crore in June 2021.'},\n {'question': 'What was the EBITDA for Apollo Hospital in June 2022, and how did it change from June 2021?',\n  'answer': 'Apollo Hospital\\'s EBITDA in June 2022 was Rs. 506.80 crore, representing a decrease of 6.93% from June 2021.',\n  'context': 'The passage states that Apollo Hospital reported an EBITDA of Rs. 506.80 crore in June 2022, marking a 6.93% decrease compared to Rs. 544.51 crore in June 2021.'},\n {'question': 'What was the change in Apollo Hospital\\'s EPS from June 2021 to June 2022?',\n  'answer': 'Apollo Hospital\\'s EPS decreased from Rs. 34.03 in June 2021 to Rs. 22.05 in June 2022.',\n  'context': 'The financial data reveals that Apollo Hospital\\'s EPS stood at Rs. 22.05 in June 2022, down from Rs. 34.03 in June 2021.'},\n {'question': 'What was the closing price of Apollo Hospital shares on August 11, 2022, on the NSE?',\n  'answer': 'Apollo Hospital shares closed at 4429.65 on the NSE on August 11, 2022.',\n  'context': 'The text indicates that on August 11, 2022, Apollo Hospital\\'s shares closed at a price of 4429.65 on the National Stock Exchange (NSE).'},\n {'question': 'What were the 6-month returns for Apollo Hospital shares as of August 11, 2022?',\n  'answer': 'As of August 11, 2022, Apollo Hospital shares had generated returns of 1.89% over the past 6 months.',\n  'context': 'The provided information highlights that Apollo Hospital shares provided a return of 1.89% over the 6 months leading up to August 11, 2022.'},\n {'question': 'What was the 12-month return for Apollo Hospital shares as of August 11, 2022?',\n  'answer': 'Apollo Hospital shares provided a 10.02% return over the 12 months leading up to August 11, 2022.',\n  'context': 'According to the data, Apollo Hospital shares yielded a return of 10.02% for the 12-month period ending on August 11, 2022.'},\n {'question': 'Did Apollo Hospital experience growth or decline in Net Sales and Net Profit in June 2022 compared to the previous year?',\n  'answer': 'Apollo Hospital witnessed growth in Net Sales but a decline in Net Profit in June 2022 compared to June 2021.',\n  'context': 'The financial results indicate that Apollo Hospital's Net Sales showed a slight increase of 0.94% in June 2022 compared to the same period in the previous year. However, their Quarterly Net Profit experienced a significant decrease of 35.19% during the same period.'}]",
    "[\n    {\n        \"question\": \"What was Apollo Hospital's net sales in June 2022?\",\n        \"answer\": \"Apollo Hospital's net sales in June 2022 were Rs. 1529.69 crore.\",\n        \"context\": \"Net Sales at Rs 1529.69 crore in June 2022 down 48.92  from Rs. 2994.71 crore in June 2021.\"\n    },\n    {\n        \"question\": \"How much was Apollo Hospital's quarterly net profit in June 2021?\",\n        \"answer\": \"Apollo Hospital's quarterly net profit in June 2021 was Rs. 150.04 crore.\",\n        \"context\": \"Quarterly Net Profit at Rs. 333.14 crore in June 2022 up 122.03  from Rs. 150.04 crore in June 2021.\"\n    },\n    {\n        \"question\": \"What is Apollo Hospital's EBITDA in June 2022?\",\n        \"answer\": \"Apollo Hospital's EBITDA in June 2022 was Rs. 398.86 crore.\",\n        \"context\": \"EBITDA stands at Rs. 398.86 crore in June 2022 down 0.12  from Rs. 399.33 crore in June 2021.\"\n    },\n    {\n        \"question\": \"What is Apollo Hospital's EPS in June 2021?\",\n        \"answer\": \"Apollo Hospital's EPS in June 2021 was Rs. 10.44.\",\n        \"context\": \"Apollo Hospital EPS has increased to Rs. 23.17 in June 2022 from Rs. 10.44 in June 2021.\"\n    },\n    {\n        \"question\": \"What is the current share price of Apollo Hospital on the NSE?\",\n        \"answer\": \"Apollo Hospital shares closed at 4429.65 on August 11 2022 (NSE).\",\n        \"context\": \"Apollo Hospital shares closed at 4429.65 on August 11 2022 (NSE) and has given 1.89  returns over the last 6 months and 10.02  over the last 12 months.\"\n    },\n    {\n        \"question\": \"What is Apollo Hospital's return over the last 6 months?\",\n        \"answer\": \"Apollo Hospital has given 1.89% returns over the last 6 months.\",\n        \"context\": \"Apollo Hospital shares closed at 4429.65 on August 11 2022 (NSE) and has given 1.89  returns over the last 6 months and 10.02  over the last 12 months.\"\n    },\n    {\n        \"question\": \"What is Apollo Hospital's return over the last 12 months?\",\n        \"answer\": \"Apollo Hospital has given 10.02% returns over the last 12 months.\",\n        \"context\": \"Apollo Hospital shares closed at 4429.65 on August 11 2022 (NSE) and has given 1.89  returns over the last 6 months and 10.02  over the last 12 months.\"\n    },\n    {\n        \"question\": \"What was Apollo Hospital's percentage change in net sales from June 2021 to June 2022?\",\n        \"answer\": \"Apollo Hospital's net sales decreased by 48.92% from June 2021 to June 2022.\",\n        \"context\": \"Net Sales at Rs 1529.69 crore in June 2022 down 48.92  from Rs. 2994.71 crore in June 2021.\"\n    }\n]",
    "[{'question': 'What is the outlook for the Indian equity market following the recent market decline, according to Sameet Chavan of Angel One?',\n  'answer': 'Sameet Chavan suggests a cautious approach, recommending investors \"stay light on positions\" and focus on stock-specific opportunities. While he acknowledges the market\\'s inability to show strength at higher levels, he also notes a lack of convincing weakness. He advises reassessing the situation in the coming week, with key levels to watch being 16,000 on the downside and 16,400 on the upside for the Nifty50.',\n  'context': 'The Indian equity market is currently facing uncertainty after a significant decline.  Market expert Sameet Chavan, Chief Analyst-Technical and Derivatives at Angel One, suggests a cautious approach for investors. While he acknowledges the market\\'s struggle to gain momentum at higher levels, he also hasn\\'t observed convincing signs of a continued downward trend.  He advises against taking large positions and instead recommends focusing on individual stock opportunities, especially considering the recent volatility and \"whipsaws\" observed in the market. Chavan emphasizes the importance of the 16,000 and 16,400 levels for the Nifty50 as potential indicators for future market direction. '},\n {'question': 'What factors contributed to the negative performance of the Indian equity market, resulting in a more than 2 percent loss and reversing the previous week\\'s gains?',\n  'answer': 'The Indian equity market\\'s decline was driven by several factors, including global peer nervousness, persistent inflation concerns, and sustained foreign institutional investor (FII) selling. The Reserve Bank of India\\'s increased inflation forecast for FY23 by 100 bps to 6.7 percent and the US inflation reaching a 40-year high of 8.6 percent fueled these concerns. Additional factors impacting the market sentiment included worries about growth, China\\'s imposition of further Covid restrictions, and oil prices remaining above $120 per barrel.',\n  'context': 'The Indian equity market experienced a decline of over 2 percent, erasing the previous week\\'s gains. This downturn can be attributed to a confluence of negative factors. Global market anxiety, persistent inflation fears, and continuous selling by foreign institutional investors (FIIs) played significant roles. The Reserve Bank of India\\'s upward revision of the inflation forecast to 6.7 percent for FY23 and the US inflation surging to a 40-year high of 8.6 percent exacerbated these concerns. Additionally, worries about economic growth, China\\'s implementation of additional Covid restrictions, and oil prices remaining elevated above $120 per barrel further dampened market sentiment.'},\n {'question': 'What is the rationale behind Vaishali Parekh\\'s \"Buy\" recommendation for TVS Motor Company, and what are the target and stop-loss levels?',\n  'answer': 'Vaishali Parekh, VP Technical Research at Prabhudas Lilladher, recommends buying TVS Motor Company stock with a target price of Rs 850 and a stop-loss at Rs 730. The rationale is based on the stock\\'s breakout above Rs 750 after initially breaking out above the Rs 690 zone in an \"Inverted Head and Shoulder\" pattern. The strong bias and potential for further upside, with targets of Rs 820-850, make it an attractive buy. ',\n  'context': 'Vaishali Parekh of Prabhudas Lilladher identifies a buying opportunity in TVS Motor Company stock. Her analysis highlights a bullish \"Inverted Head and Shoulder\" pattern breakout above Rs 690, followed by a further breakout above Rs 750, indicating strong upward momentum. This observation, coupled with a positive bias and potential for further gains towards Rs 820-850 levels, forms the basis of the \"Buy\" recommendation. To manage risk, a stop-loss at Rs 730 is advised, providing a favorable risk-reward ratio for potential investors.'},\n {'question': 'Why does Jatin Gohil from Reliance Securities suggest buying Deepak Nitrite, and what is the reasoning behind the price targets?',\n  'answer': 'Jatin Gohil, Technical and Derivative Research Analyst at Reliance Securities, recommends buying Deepak Nitrite based on its June 9th reversal after testing its horizontal support line and subsequent gains. The stock\\'s daily RSI (relative strength index) signaling a buy after a bullish divergence reinforces this positive outlook.  Gohil anticipates the stock reaching its short-term supply zone of Rs 2035-2050 initially and potentially its long-term moving average of 200-day SMA (Rs 2278) subsequently.  He sets a stop-loss at Rs 170\"\n    }\n]\n",
    "[{'question': 'What were Apollo Hospital\\'s net sales in March 2022?', 'answer': 'Apollo Hospital reported net sales of Rs 3546.43 crore in March 2022.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'How did Apollo Hospital\\'s net sales in March 2022 compare to March 2021?', 'answer': 'Apollo Hospital\\'s net sales increased by 23.66%, reaching Rs 3546.43 crore in March 2022 from Rs. 2867.95 crore in March 2021.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'What was Apollo Hospital\\'s quarterly net profit in March 2022?', 'answer': 'Apollo Hospital reported a quarterly net profit of Rs. 90.14 crore in March 2022.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'How did Apollo Hospital\\'s quarterly net profit in March 2022 compare to the same period in 2021?', 'answer': 'Apollo Hospital\\'s quarterly net profit decreased by 46.3% in March 2022, dropping to Rs. 90.14 crore from Rs. 167.86 crore in March 2021.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'What was Apollo Hospital\\'s EBITDA in March 2022?', 'answer': 'Apollo Hospital recorded an EBITDA of Rs. 493.96 crore in March 2022.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'How did Apollo Hospital\\'s EBITDA change from March 2021 to March 2022?', 'answer': 'Apollo Hospital\\'s EBITDA grew by 14.27%, reaching Rs. 493.96 crore in March 2022 from Rs. 432.28 crore in March 2021.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'What was the EPS for Apollo Hospital in March 2022?', 'answer': 'Apollo Hospital\\'s EPS decreased to Rs. 6.27 in March 2022 from Rs. 11.77 in March 2021.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net profit, EBITDA, and EPS for March 2022 and March 2021. It allows for a comparative analysis of the company\\'s financial health year-over-year.'}, {'question': 'What was the closing price of Apollo Hospital\\'s shares on May 25, 2022, on the NSE?', 'answer': 'Apollo Hospital\\'s shares closed at 3524.30 on May 25, 2022, on the NSE.', 'context': 'The provided data presents a summary of Apollo Hospital\\'s financial performance, highlighting key metrics like net sales, net\"\n    }\n]\n",
    "[{'question': 'What was the percentage change in Apollo Hospital\\'s net sales between March 2021 and March 2022?',\n  'answer': 'Apollo Hospital\\'s net sales decreased by 41.05% between March 2021 and March 2022.',\n  'context': 'In March 2022, Apollo Hospital recorded net sales of Rs 1420.73 crore, a significant decrease from Rs. 2410.07 crore in March 2021. This represents a decline of 41.05% in net sales year-over-year.'},\n {'question': 'How did Apollo Hospital\\'s quarterly net profit in March 2022 compare to March 2021?',\n  'answer': 'Apollo Hospital\\'s quarterly net profit showed a positive trend, increasing by 33.02% from Rs. 115.52 crore in March 2021 to Rs. 153.67 crore in March 2022.',\n  'context': 'Despite the decline in net sales, Apollo Hospital witnessed growth in its quarterly net profit. The company reported a net profit of Rs. 153.67 crore in March 2022, compared to Rs. 115.52 crore in March 2021, marking a 33.02% rise.'},\n {'question': 'What was the EBITDA of Apollo Hospital in March 2022, and how did it change compared to March 2021?',\n  'answer': 'Apollo Hospital\\'s EBITDA in March 2022 was Rs. 350.71 crore, reflecting a slight increase of 1.19% from Rs. 346.57 crore in March 2021.',\n  'context': 'The Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) for Apollo Hospital in March 2022 reached Rs. 350.71 crore, indicating a marginal growth of 1.19% from Rs. 346.57 crore in March 2021. This suggests a relatively stable operational performance despite the drop in net sales.'},\n {'question': 'What is the change in Apollo Hospital\\'s EPS from March 2021 to March 2022?',\n  'answer': 'Apollo Hospital\\'s EPS rose from Rs. 8.10 in March 2021 to Rs. 10.69 in March 2022, indicating an increase in profitability on a per-share basis.',\n  'context': 'The Earnings Per Share (EPS) of Apollo Hospital experienced a positive shift, increasing to Rs. 10.69 in March 2022 from Rs. 8.10 in March 2021. This improvement in EPS reflects the company\\'s enhanced profitability relative to the number of outstanding shares.'},\n {'question': 'What was the closing price of Apollo Hospital\\'s shares on May 25, 2022, according to the NSE?',\n  'answer': 'On May 25, 2022, Apollo Hospital\\'s shares closed at Rs. 3524.30 on the National Stock Exchange (NSE).',\n  'context': 'As of May 25, 2022, Apollo Hospital\\'s shares on the National Stock Exchange (NSE) concluded trading at a closing price of Rs. 3524.30. This information reflects the market sentiment and valuation of the company\\'s stock on that particular date.'},\n {'question': 'What return did Apollo Hospital\\'s stock generate for investors over the past six months as of May 25, 2022?',\n  'answer': 'Apollo Hospital\\'s stock provided investors with a significant return of 38.18% over the six-month period leading up to May 25, 2022.',\n  'context': 'Analyzing the performance of Apollo Hospital\\'s stock over the six months preceding May 25, 2022, investors enjoyed a substantial return of 38.18%. This indicates a positive price appreciation, suggesting favorable market sentiment towards the company\\'s future prospects.'},\n {'question': 'How did Apollo Hospital\\'s stock perform in the 12 months leading up to May 25, 2022, in terms of returns?',\n  'answer': 'In the one-year timeframe ending May 25, 2022, Apollo Hospital\\'s stock generated a return of\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"What is the recommended trading strategy for Apollo Hospitals Enterprises according to Angel Broking's Ruchit Jain?\",\n        \"answer\": \"Ruchit Jain recommends buying Apollo Hospitals Enterprises on a breakout above Rs 5000, or holding existing long positions until the stock drops below its 200 EMA support at Rs 4425.\",\n        \"context\": \"After a period of consolidation above its 200-day exponential moving average (EMA) of Rs 4425, Apollo Hospitals Enterprises is facing resistance at Rs 5000.  A breakout above this level could signal the next leg of a directional move.  Investors should consider buying on a breakout above Rs 5000 or holding existing long positions until support at the 200 EMA is broken.\"\n    },\n    {\n        \"question\": \"What is Ruchit Jain's outlook on MRPL and what trading strategy does he suggest?\",\n        \"answer\": \"Jain acknowledges MRPL's recent breakout above its previous high but advises caution due to an overbought RSI. He suggests waiting for a corrective dip and buying at around Rs 54 with a target of Rs 70 and a stop-loss at Rs 48.\",\n        \"context\": \"MRPL has broken out above its previous high resistance with strong volume, indicating buying interest. However, the RSI is around 90, suggesting an overbought condition. Jain recommends waiting for a pullback within the uptrend and buying on dips towards the support level of Rs 54.  A target of Rs 70 is suggested, with a stop-loss below Rs 48.\"\n    },\n    {\n        \"question\": \"What trading strategy does Ruchit Jain recommend for Minda Corporation?\",\n        \"answer\": \"Jain suggests buying Minda Corporation on dips around its previous resistance level of Rs 230, with a target of Rs 275 and a stop-loss below Rs 218.\",\n        \"context\": \"Minda Corporation is in an uptrend and has broken above its previous resistance at Rs 230. This level is now expected to act as support. Jain recommends buying on dips towards Rs 230, targeting Rs 275 in the coming months.  A stop-loss below Rs 218 is advised.\"\n    },\n    {\n        \"question\": \"What is Ruchit Jain's perspective on Genus Paper and Boards, and what trading strategy does he recommend?\",\n        \"answer\": \"Jain is bullish on Genus Paper and Boards due to its \"Higher Top Higher Bottom\" formation and positive momentum. He advises accumulating the stock between Rs 20-21 with a target of Rs 25 and a stop-loss below Rs 19.\",\n        \"context\": \"Genus Paper and Boards is exhibiting a \"Higher Top Higher Bottom\" pattern, a bullish signal. The stock is showing positive momentum, supported by strong volume. Jain recommends accumulating shares within the Rs 20-21 range, with a potential target of Rs 25.  A stop-loss below Rs 19 is recommended.\"\n    },\n    {\n        \"question\": \"What is Ruchit Jain's view on Vaishali Pharma's current market position and what does he suggest investors do?\",\n        \"answer\": \"While Jain acknowledges Vaishali Pharma's strong uptrend, he warns that it's overbought. He advises against new entries and suggests existing holders ride the trend with a trailing stop-loss, noting support at Rs 95.\",\n        \"context\": \"Vaishali Pharma has experienced a significant rally, rising from Rs 40 to over Rs 110. Although the trend remains positive, oscillators indicate an overbought condition. Jain cautions against initiating new long positions due to an unfavorable risk/reward ratio. He advises existing holders to maintain their positions while employing a trailing stop-loss, highlighting support around Rs 95.\"\n    },\n    {\n        \"question\": \"How did the Indian stock market perform, and what were the key influencing factors?\",\n        \"answer\": \"The Indian stock market initially showed signs of recovery but succumbed to selling pressure due to the Ukraine war, leading to a fifth consecutive day of losses. Benchmark indices like the Sensex and Nifty fell over 1%, with IT and FMCG sectors hit hardest.\",\n        \"context\": \"Despite a positive opening, the Indian stock market reversed gains and closed lower for the fifth straight session.  The decline was attributed to the ongoing conflict in Ukraine.  Benchmark indices, the BSE Sensex and Nifty50, dropped more than 1%.  Selling was widespread, with IT and FMCG sectors experiencing the most significant losses.\"\n    },\n    {\"\n    }\n]\n",
    "[\n  {\n    \"question\": \"How much did the BSE Sensex fall?\",\n    \"answer\": \"The BSE Sensex fell 383 points to 57301.\",\n    \"context\": \"The BSE Sensex fell 383 points to 57301 and the Nifty50 declined 115 points to 17092.\"\n  },\n  {\n    \"question\": \"Which sectors were the top losers?\",\n    \"answer\": \"The top losing sectors were IT, FMCG, and Metal, each falling 1 percent.\",\n    \"context\": \"All sectoral indices closed in the red with IT FMCG and Metal being the top losers falling 1 percent each.\"\n  },\n  {\n    \"question\": \"Which stocks were the biggest gainers in the futures and options segment?\",\n    \"answer\": \"The biggest gainers in the futures and options segment were NALCO, Apollo Hospitals Enterprises, and Metropolis Healthcare.\",\n    \"context\": \"Stocks that were in focus include NALCO Apollo Hospitals Enterprises and Metropolis Healthcare which were the second third and fourth biggest gainers respectively in the futures and options segment.\"\n  },\n  {\n    \"question\": \"What is the recommended stop-loss level for NALCO?\",\n    \"answer\": \"The recommended stop-loss level for NALCO is Rs 108.\",\n    \"context\": \"Stoploss suggested for this trade will be a close below Rs 108 levels.\"\n  },\n  {\n    \"question\": \"What is the initial target for the pullback attempt in Apollo Hospitals Enterprises?\",\n    \"answer\": \"The initial target for the pullback attempt in Apollo Hospitals Enterprises is Rs 4794.\",\n    \"context\": \"However initial target for this pullback attempt shall be Rs 4794 levels and a close above that shall confirm a sustainable upmove.\"\n  },\n  {\n    \"question\": \"What is the medium-term trend for Metropolis Healthcare?\",\n    \"answer\": \"The medium-term trend for Metropolis Healthcare is down.\",\n    \"context\": \"In case as mediumterm trend is down if this counter registers a close below Rs 1870 levels then it can slide down all the way to Rs 1550.\"\n  },\n  {\n    \"question\": \"What is the recommended stop-loss level for Metropolis Healthcare?\",\n    \"answer\": \"The recommended stop-loss level for Metropolis Healthcare is Rs 1925.\",\n    \"context\": \"If someone is holding then they are advised to maintain a stoploss below Rs 1925 levels.\"\n  },\n  {\n    \"question\": \"What is the initial target for the pullback attempt in Indiabulls Real Estate?\",\n    \"answer\": \"The initial target for the pullback attempt in Indiabulls Real Estate is Rs 132.\",\n    \"context\": \"Hence sustaining above Rs 99 levels it can make a pullback attempt with initial targets of Rs 132 levels.\"\n  }\n]",
    "```python\n[\n    {\n        \"question\": \"What is the short-term outlook for Nifty according to Santosh Meena of Swastika Investmart?\",\n        \"answer\": \"According to Santosh Meena, Nifty is facing resistance at the 20DMA level of 17325. A break above this level could lead to a rally towards 17600-17800. However, if Nifty breaks below the 200DMA at 16877, it could fall further towards 16400-16000.\",\n        \"context\": \"Santosh Meena, Head of Research at Swastika Investmart, observes that Nifty is currently respecting its 200DMA (16877) which is providing confidence to the bulls. However, the 20DMA (17325) is acting as a strong resistance. A break above 17325 could take Nifty towards 17600-17800. On the downside, a break below the 200DMA could lead to a fall towards 16400-16000.\"\n    },\n    {\n        \"question\": \"What is the significance of FII activity in the current market scenario as per Swastika Investmart's analysis?\",\n        \"answer\": \"Santosh Meena points out that although FIIs are still selling in the cash market, the momentum has reduced. Moreover, they have been building bullish positions in the F&O market for the past few days, which is a positive sign.\",\n        \"context\": \"Santosh Meena highlights that FIIs are continuing to sell in the cash market, but the selling pressure has eased. However, a positive development is that FIIs have been taking bullish bets in the futures and options market recently. This suggests a potential shift in sentiment.\"\n    },\n    {\n        \"question\": \"What are the key support and resistance levels for Nifty and Bank Nifty based on open interest data according to Swastika Investmart?\",\n        \"answer\": \"Based on open interest data, Swastika Investmart identifies 17000 as a strong support level for Nifty, particularly ahead of the expiry. For Bank Nifty, the critical support zone is placed at 37000-36500.\",\n        \"context\": \" Analyzing the open interest data, Santosh Meena indicates that 17000 will act as a crucial support level for Nifty, especially as the expiry approaches. For Bank Nifty, the 37000-36500 range is expected to provide strong support.\"\n    },\n    {\n        \"question\": \"Why does Swastika Investmart recommend buying Apollo Hospitals, and what is the price target?\",\n        \"answer\": \"Swastika Investmart recommends buying Apollo Hospitals with a target price of Rs 5100. This is based on the stock finding support at its 200DMA, forming a bullish Engulfing candlestick pattern, and showing positive signals from RSI and MACD indicators.\",\n        \"context\": \"Swastika Investmart has issued a buy call for Apollo Hospitals with a target of Rs 5100. The rationale behind this recommendation is the stock taking support at its 200DMA and forming a bullish Engulfing candlestick pattern after a correction. Additionally, the RSI indicator is showing a positive crossover with positive divergence, and the MACD indicator also indicates a positive crossover.  \"\n    },\n    {\n        \"question\": \"What is the technical outlook for L&T Infotech according to Swastika Investmart, and what is the target price?\",\n        \"answer\": \"Swastika Investmart is bullish on L&T Infotech with a target price of Rs 6600. This is based on the stock forming a strong base at its 200DMA (around Rs 5600), showing a bullish candlestick formation, and having positive divergence in momentum indicators.\",\n        \"context\": \"Swastika Investmart believes L&T Infotech presents a buying opportunity with a target of Rs 6600. The stock has established a strong base around its 200DMA near the Rs 5600 level and formed a bullish candlestick pattern with positive divergence in momentum indicators. A break above the 20DMA at Rs 6075 could drive the stock towards the 100DMA and 50DMA cluster around Rs 6600.\"\n    },\n    {\n        \"question\": \"What is the rationale behind Swastika Investmart's buy call for Minda Corporation, and what is the price target?\",\n        \"answer\": \"Swastika Investmart recommends buying Minda Corporation\"\n    }\n]\n",
    "```python\n[\n    {\n        \"question\": \"What is the recommended trading strategy for Prestige Estates Projects according to Mazhar Mohammad of Chartviewindia.in?\",\n        \"answer\": \"Mazhar Mohammad recommends that fresh longs in Prestige Estates Projects are not advised unless it closes above Rs 555 levels. Positional traders who own the stock can either book profits and wait for a breakout above Rs 555 with a stop-loss below Rs 522 or exit if it fails to close above Rs 555 in the next two sessions.\",\n        \"context\": \"Prestige Estates Projects hit a fresh record high but retreated to close with a 2.77 percent gain.  Despite hitting lifetime highs, the medium-term trend seems to be sideways in a broader range of Rs 520 to Rs 400.  The upper bound of this range has acted as a supply point, while the lower boundary has witnessed buying interest.  The stock gave up all intraday gains to close around the session's low, suggesting further selling pressure if it trades below Rs 522 levels.  A close above Rs 555 could lead to an initial target of Rs 590.\"\n    },\n    {\n        \"question\": \"What is the outlook for Apollo Hospitals Enterprises according to Mazhar Mohammad?\",\n        \"answer\": \"Mazhar Mohammad believes that Apollo Hospitals Enterprises has witnessed critical breakdowns on weekly charts, erasing a four-week-old pullback attempt. This suggests more selling pressure, with initial targets of Rs 4351 levels and a potential further decline towards Rs 3955 levels. Fresh long-side bets should be avoided for now.\",\n        \"context\": \"Apollo Hospitals was the fifth biggest loser in the futures and options segment, falling 6 percent. This erased a four-week-old pullback attempt from the lows of Rs 4643 to a high of Rs 5148, indicating a faster retracement on the downside. This hints at more selling pressure, with initial targets of Rs 4351 levels and a potential further decline towards Rs 3955 levels.\"\n    },\n    {\n        \"question\": \"What is Mazhar Mohammad's analysis of Gujarat Ambuja Exports' recent performance?\",\n        \"answer\": \"Mazhar Mohammad observes that Gujarat Ambuja Exports' sharp upmove in the last two trading sessions, backed by massive volumes, suggests a potential breakout above its 94-day-old corrective and consolidation phase. This, combined with the stock trading close to its life highs of Rs 202, points to a possible trend reversal with a sustainable upmove, with a higher target of Rs 219.\",\n        \"context\": \"Gujarat Ambuja Exports rallied 3.96 percent. The last two trading sessions of sharp upmove on the back of massive volumes may be hinting at a breakout above its 94-day-old corrective and consolidation phase. Volumes with sharp price appreciation may be pointing at a trend reversal with a sustainable upmove. Moreover, as this counter is trading close to its life highs of Rs 202, a higher target of Rs 219 can't be ruled out.\"\n    },\n    {\n        \"question\": \"What trading strategy does Mazhar Mohammad suggest for Infibeam Avenues?\",\n        \"answer\": \"Mazhar Mohammad advises positional traders to adopt a two-pronged strategy for Infibeam Avenues: buy now and add on dips in the zone of Rs 42-40 levels, with an initial target of Rs 57. A stop-loss below Rs 39 is suggested. This is based on the stock's recent sharp price rise on the back of massive volumes after a period of consolidation.\",\n        \"context\": \"Infibeam Avenues rallied 8.5 percent. The stock appears to be in a multi-week consolidation zone of Rs 58-37 for the last 10 months. However, the last four weeks of price structure is in extremely narrow ranges and seems to have formed a decent base around Rs 39. This was followed by a sharp price rise on the back of massive volumes.\"\n    },\n    {\n        \"question\": \"Why does Mazhar Mohammad advise against fresh longs in Prestige Estates Projects unless it closes above Rs 555?\",\n        \"answer\": \"Mazhar Mohammad advises against fresh longs in Prestige Estates Projects unless it closes above Rs 555 because the stock gave up all its intraday gains and closed near the session's low. This, combined with the stock's recent trading pattern within a defined range, suggests potential further selling pressure if it trades below Rs 522 levels.\",\n        \"context\": \"Prestige Estates Projects, despite hitting record highs, closed near the day'\"\n    }\n]\n",
    "```\n[\n  {\n    \"question\": \"What was the percentage increase in the benchmark indices at the end of the weekly session on January 7th?\",\n    \"answer\": \"2.5 percent\",\n    \"context\": \"Dalal Street stayed upbeat for yet another week as the market entered the New Year on a bullish note driving the benchmark indices up over 2.5 percent by the end of the weekly session on January 7.\"\n  },\n  {\n    \"question\": \"Which sectors were the key drivers for the rally?\",\n    \"answer\": \"Banking and financials\",\n    \"context\": \"Banking and financials were the key drivers for the rally.\"\n  },\n  {\n    \"question\": \"What is the crucial level for a sharp uptrend in the coming days according to experts?\",\n    \"answer\": \"18000\",\n    \"context\": \"Experts largely feel 18000 will be crucial for a sharp uptrend in the coming days and as long as the index holds 20week simple moving average of 17553 then the positive momentum would continue however 17640 is going to be a crucial support.\"\n  },\n  {\n    \"question\": \"What is the key resistance level for the Nifty50?\",\n    \"answer\": \"18000\",\n    \"context\": \"Looking at the price action the psychological level of 18000 will act as a key resistance level.\"\n  },\n  {\n    \"question\": \"What is the key support level for the Nifty50?\",\n    \"answer\": \"17640\",\n    \"context\": \"The key support level is placed at 17640 (Multiple touch point level) we expect this to act as a key support level going forward\"\n  },\n  {\n    \"question\": \"What is the maximum open interest in the options data?\",\n    \"answer\": \"18000 CE and 17500 PE\",\n    \"context\": \"Looking at the options data 18000 CE and 17500 PE have the maximum open interest.\"\n  },\n  {\n    \"question\": \"What is the expected range for the index according to experts?\",\n    \"answer\": \"17500-18000\",\n    \"context\": \"We expect the index to be in the range of 1750018000.\"\n  },\n  {\n    \"question\": \"What is the first trading idea by expert Vinay Rajani?\",\n    \"answer\": \"Buy Chambal Fertilisers\",\n    \"context\": \"Here are 10 trading ideas by experts for the next 34 weeks.\\nReturns are based on January 7 closing prices\\nExpert  Vinay Rajani Senior Technical   Derivative Analyst at HDFC Securities\\nChambal Fertilisers  Buy   LTP  Rs 423.15   StopLoss  Rs 384   Target  Rs 499   Return  18 percent\"\n  }\n]\n```\"\n    }\n]\n",
    "[\n    {\n        \"question\": \"What was the market's performance on December 17?\",\n        \"answer\": \"The market was caught in a bear trap on December 17.\",\n        \"context\": \"The market was caught in a bear trap on December 17 as well as for the entire last week amid relentless FII selling hawkish stance by the Federal Reserve and a surprise rate hike by the Bank of England.\"\n    },\n    {\n        \"question\": \"Which sectors closed in the negative terrain on December 17?\",\n        \"answer\": \"All sectors barring IT closed in the negative terrain on December 17.\",\n        \"context\": \"All sectors barring IT closed in the negative terrain with bank auto financial services FMCG and metal indices losing 22.5 percent.\"\n    },\n    {\n        \"question\": \"What is Rajesh Palviya's recommendation for Persistent Systems?\",\n        \"answer\": \"Rajesh Palviya recommends investors buy Persistent Systems with a short-term support zone of Rs 4400-4200 and an expected upside of Rs 4800-4900.\",\n        \"context\": \"The shortterm support zone is placed at Rs 44004200 levels with the expected upside of Rs 48004900 levels.\"\n    },\n    {\n        \"question\": \"What caused the breakout in Wipro's stock price?\",\n        \"answer\": \"Wipro's stock price breakout was accompanied by huge volumes indicating increased participation.\",\n        \"context\": \"This breakout is accompanied by huge volumes indicating increased participation.\"\n    },\n    {\n        \"question\": \"What is the short-term bias for Apollo Hospitals Enterprises?\",\n        \"answer\": \"The short-term bias for Apollo Hospitals Enterprises remains weak with an upside resistance zone of Rs 5200-5300.\",\n        \"context\": \"The shortterm bias remains weak with an upside resistance zone of Rs 52005300 levels.\"\n    },\n    {\n        \"question\": \"What is the technical analysis for Zee Entertainment Enterprises?\",\n        \"answer\": \"On the weekly chart the past couple of weeks  price action has formed an  engulfing bearish   a shortterm trend reversal pattern. However any followup down close below Rs 338 levels will confirm the abovementioned pattern.\",\n        \"context\": \"On the weekly chart the past couple of weeks  price action has formed an  engulfing bearish   a shortterm trend reversal pattern.\"\n    },\n    {\n        \"question\": \"What has been the trend for Indiabulls Housing Finance since June 2021?\",\n        \"answer\": \"Since June 2021 Indiabulls Housing Finance has been consolidating within a broad range of Rs 290-200 indicating a sideways trend.\",\n        \"context\": \"Since June 2021 the stock has been consolidating within a broad range of Rs 290200 levels representing a sideways trend.\"\n    },\n    {\n        \"question\": \"What is the overall bias for Indiabulls Housing Finance?\",\n        \"answer\": \"The overall bias for Indiabulls Housing Finance remains neutral to negative with a downside support zone of Rs 200-190.\",\n        \"context\": \"Overall bias remains neutral to negative with a downside support zone of Rs 200190 levels.\"\n    }\n]",
    "[{'question': 'What is the outlook for Apollo Hospitals Enterprises according to Globe Capital Markets?',\n  'answer': 'Globe Capital Markets sees Apollo Hospitals Enterprises, the largest healthcare stock by market capitalization, as well-positioned among its peers. They highlight its recent rally and a breakout on weekly charts with strong volume, suggesting a potential target of Rs 6200.',\n  'context': 'The analysis of Apollo Hospitals Enterprises comes from Gaurav Sharma of Globe Capital Markets.  They point out the stock\\'s strong performance, having rallied significantly in recent sessions. The breakout on weekly charts, accompanied by strong volume, is cited as a bullish signal. Sharma suggests this points to a potential target of Rs 6200 for the stock.'},\n {'question': 'How does Globe Capital Markets recommend investors approach L T Technology Services?',\n  'answer': 'Globe Capital Markets advises investors to stay invested in L T Technology Services for the medium to long term, citing its strong uptrend. They also suggest that those who haven\\'t invested yet can consider buying during dips.',\n  'context': 'Gaurav Sharma of Globe Capital Markets identifies L T Technology Services as a stock in a strong uptrend, characterized by higher highs and higher lows over a prolonged period. They acknowledge the stock\\'s resilience during the initial COVID-19 impact, noting its subsequent recovery and substantial growth. Based on this performance history, Sharma recommends a long-term bullish stance on L T Technology Services.'},\n {'question': 'What is the technical analysis perspective on Tanla Platforms according to Globe Capital Markets?',\n  'answer': 'Globe Capital Markets observes that Tanla Platforms has broken out of a consolidation range and surpassed its upside target. While some profit-taking is possible, they believe the overall trend remains strong and dips should be viewed as buying opportunities.',\n  'context': 'Globe Capital Markets\\' analysis highlights Tanla Platforms\\' recent breakout from a period of consolidation. The stock\\'s rapid ascent and trading at the upper circuit indicate strong upward momentum. While acknowledging the possibility of profit-taking, they emphasize that the overall trend remains bullish. They recommend viewing any dips as potential buying opportunities.'},\n {'question': 'How does Globe Capital Markets view the recent correction in Barbeque Nation Hospitality\\'s stock?',\n  'answer': 'Globe Capital Markets sees the correction in Barbeque Nation Hospitality as a healthy retracement and a good buying opportunity. They believe the restaurant sector is poised for a strong quarter ahead, assuming there is no significant impact from a third COVID-19 wave in India.',\n  'context': 'Globe Capital Markets interprets the recent pullback in Barbeque Nation Hospitality\\'s stock as a normal correction within a broader uptrend. They apply Fibonacci Retracement theory to suggest a potential recovery. Additionally, they express optimism about the restaurant sector\\'s prospects, assuming the absence of major disruptions from the pandemic. This positive outlook, coupled with the technical analysis, leads them to view the current price levels as a favorable entry point.'}]",
    "```python\n[\n    {  \"question\": \"What is the short-term market sentiment for Nifty50?\",\n        \"answer\": \"The market sentiment for Nifty50 is currently neutral for the short to medium term, as indicated by the RSI sustaining near 50 levels on the daily charts.\", \n        \"context\": \"The momentum indicator like RSI (relative strength index) is sustaining near 50 levels on the daily charts which indicates neutral sentiment for the index for the short to medium term.\"\n    },\n    {  \"question\": \"What is the expected price range for Nifty50 in the near future?\",\n        \"answer\": \"Nifty50 is expected to be range-bound between 17600 and 18200 levels in the near future.\", \n        \"context\": \"We believe Nifty could be rangebound between 18200 and  17600 levels.\"\n    },\n    {  \"question\": \"Why is Birlasoft considered a good buy opportunity?\",\n        \"answer\": \"Birlasoft is considered a good buy opportunity due to a strong consolidation breakout with volume confirmation, a fresh lifetime high indicating bullish undertone, and strong support at the 20-week SMA since June 2020.\", \n        \"context\": \"Birlasoft has given a strong consolidation breakout with a volume confirmation which has been forming since last 5 months and made a fresh life time high which shows strong bullish undertone of the stock for medium to long term. The stock has been taking strong support at 20week SMA (simple moving average) since June 2020 indicating the stock is in long term bullish phase.\"\n    },\n    {  \"question\": \"What technical indicators support the bullish outlook for Birlasoft?\",\n        \"answer\": \"The RSI sustaining above 60 levels on all timeframes confirms strong positive momentum for Birlasoft, supporting the bullish outlook.\", \n        \"context\": \"The momentum indicator RSI has sustained above 60 levels on all the time frames which confirms strong positive momentum of the stock for the medium to long term.\"\n    },\n    {  \"question\": \"What is the reason behind the bullish outlook on Apollo Hospitals Enterprises?\",\n        \"answer\": \"Apollo Hospitals Enterprises is considered bullish due to a strong breakout after taking support at the 20-week SMA, a fresh lifetime high at Rs 5844, and strong volume confirmation indicating strength in the upward move.\", \n        \"context\": \"Apollo Hospitals has given a strong breakout after taking a strong support at 20week SMA and made a fresh life time high at Rs 5844 levels which shows strong positive undertone of the stock for the medium to long term. The breakout is backed by the strong volume confirmation indicating the strength of the upward move.\"\n    },\n    {  \"question\": \"What price targets are projected for Apollo Hospitals Enterprises?\",\n        \"answer\": \"Apollo Hospitals Enterprises is projected to reach Rs 6520 and potentially Rs 7217 if the initial target is breached.\", \n        \"context\": \"The momentum indicators and the technical indicators all point towards the possibility of the prices moving higher towards the Rs 6520 mark immediately (61.8 percent extension level of Rs 1047   Rs 5198 projected from Rs 3955) if this level is breached we might see the prices move towards Rs 7217 (78.6 percent extension level of Rs 1047   Rs 5198 projected from Rs 3955).\"\n    },\n    {  \"question\": \"Why is L&T Technology Services (LTTS) considered a favorable investment?\",\n        \"answer\": \"LTTS is considered favorable due to consistent fresh lifetime highs since December 2020, sustaining above the 20-day SMA since May 2021, and an RSI above 60 indicating strong positive momentum.\", \n        \"context\": \"The stock has been making fresh life time highs consistently since December 2020 which shows strong positive undertone of the stock. In the current week as well the stock has made fresh life time high at Rs 5744 mark. On the daily charts the stock has been consistently sustaining above its 20day SMA since May 2021 indicating positive strength of trend.The momentum indicator like RSI is sustaining above 60 mark indicating strong positive momentum of the stock.\"\n    },\n    {  \"question\": \"What are the potential price targets for L&T Technology Services (LTTS)?\",\n        \"answer\": \"L&T Technology Services (LTTS) has potential price targets of Rs 6233 and potentially Rs 6750.\",\"\n    }\n]\n",
    "[\n  {\n    \"question\": \"What was the performance of the market on November 15?\",\n    \"answer\": \"The market gained in the morning but ended flat due to profit-booking.\",\n    \"context\": \"The market managed to add more gains in the morning on November 15 following a 1.3 percent rally in the previous trading session but profitbooking at higher levels erased those gains in the afternoon to finally settle the day on a flat note.\"\n  },\n  {\n    \"question\": \"What was Apollo Hospital Enterprises' performance in the F&O segment?\",\n    \"answer\": \"Apollo Hospital Enterprises was the biggest gainer in the F&O segment, rising 8.81 percent.\",\n    \"context\": \"Stocks that were in focus include Apollo Hospitals Enterprises which was the biggest gainer in the futures and options segment rising 8.81 percent to close at Rs 5080.95 and Syngene International which rallied 6.95 percent to Rs 593.20.\"\n  },\n  {\n    \"question\": \"What is the recommended strategy for trading in Syngene International?\",\n    \"answer\": \"Traders should adopt a two-pronged strategy of buying now and adding further on dips.\",\n    \"context\": \"As this counter appears to have just initiated a fresh leg of rally traders should adopt a twopronged strategy of buying now and adding further on dips preferably in the zone of Rs 580   Rs 560 levels by placing a stop below Rs 547 and look for a potential target of Rs 680.\"\n  },\n  {\n    \"question\": \"What is the recommended target price for IRCTC?\",\n    \"answer\": \"The potential target price for IRCTC is Rs 980.\",\n    \"context\": \"In case it closes above Rs 937 then the strength shall expand towards Rs 980.\"\n  },\n  {\n    \"question\": \"What is the technical analysis for Metropolis Healthcare?\",\n    \"answer\": \"Metropolis Healthcare has resumed its uptrend with new lifetime highs.\",\n    \"context\": \"This counter seems to have resumed its uptrend with new lifetime highs as it registered a consolidation breakout from the 23week trading range of Rs 3230 to Rs 2630 levels.\"\n  },\n  {\n    \"question\": \"What is the current trend in Nifty Midcap 100?\",\n    \"answer\": \"Nifty Midcap 100 is rising.\",\n    \"context\": \"The trend in broader markets was mixed with the Nifty Midcap 100 rising 0.32 percent and Smallcap 100 falling 0.25 percent.\"\n  },\n  {\n    \"question\": \"What was the closing value of the BSE Sensex?\",\n    \"answer\": \"The BSE Sensex closed above 60700 levels.\",\n    \"context\": \"The Nifty50 continued to respect the 20day SMA (whose value is placed at 18068) and settled above 18100 mark while the BSE Sensex closed the session above 60700 levels.\"\n  },\n  {\n    \"question\": \"Which sectors helped the benchmark indices close with a positive bias?\",\n    \"answer\": \"FMCG, IT, and pharma stocks helped the benchmark indices close with a positive bias.\",\n    \"context\": \"FMCG IT and pharma stocks helped the benchmark indices close with a positive bias however the selling pressure in metals and select banking and financial stocks capped the gains.\"\n  }\n]"
]